BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11649689)

  • 1. Is this a job for the IRB? The case of the ELISA assay.
    Holder AR
    IRB; 1985; 7(6):7-8. PubMed ID: 11649689
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for confidentiality in research on AIDS.
    Bayer R; Levine C; Murray TH
    IRB; 1984; 6(6):1-7. PubMed ID: 11649192
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 4. IRB jurisdiction and limits on IRB actions.
    Hershey N; Cann CI; Rothman KJ
    IRB; 1985; 7(2):7-9. PubMed ID: 11649624
    [No Abstract]   [Full Text] [Related]  

  • 5. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 6. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 7. Do research subjects have the right not to know their HIV antibody test results?
    Novick A; Dubler NN; Landesman SH
    IRB; 1986; 8(5):6-9. PubMed ID: 11653767
    [No Abstract]   [Full Text] [Related]  

  • 8. A look at the bioresearch monitoring program: the agency perspective.
    Brisson EL
    Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS: at the limits of the law.
    Wertheimer E
    Villanova Law Rev; 1989 Sep; 34(5):755-69. PubMed ID: 11651161
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines issued to thwart confidence crisis among AIDS research subjects.
    Med World News; 1984 Dec; 25(23):34. PubMed ID: 11645537
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 12. Can (or should) the IRB assume the FDA's functions at early stages of the IND process?
    Levine RJ
    IRB; 1981 Dec; 3(10):4-5. PubMed ID: 11649414
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical and psychological experimentation on California prisoners.
    Herch F; Flower R
    Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 15. Two rules on expedited IRB reviews are final.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract]   [Full Text] [Related]  

  • 17. The burgeoning law of medical experimentation involving human subjects.
    Bryant LE
    John Marshall J Pract Proced; 1974; 8(1):19-51. PubMed ID: 11663465
    [No Abstract]   [Full Text] [Related]  

  • 18. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG
    IRB; 1988; 10(3):6-7. PubMed ID: 11651911
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA's final regulations: IRBs and medical devices.
    Holder AR
    IRB; 1980; 2(6):1-4. PubMed ID: 11661803
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of clinical research: who's protecting who from what?
    Petricciani JC
    Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.